Importance of reference group selection in the evaluation of cancer incidence
Authors:
- Alexandra K. MuellerAMAlexandra K. Mueller
- Andrew C. ToddATAndrew C. Todd
- Christopher R. DasaroCDChristopher R. Dasaro
- Jiehui LiJLJiehui Li
- Baozhen QiaoBQBaozhen Qiao
- Paolo BoffettaPBPaolo Boffetta
- David J. PrezantDPDavid J. Prezant
- Charles B. HallCHCharles B. Hall
- David G. GoldfarbDGDavid G. Goldfarb
- Rachel Zeig-OwensRZRachel Zeig-Owens
Open Access
- 2 January 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Abstract
Elevated cancer incidence has been reported among World Trade Center (WTC)-exposed responders, with some incidence rate ratios (IRRs) varying over time. This study describes the influence that different reference populations have on relative cancer incidence and temporal trends. Participants from the WTC Combined Rescue/Recovery Cohort (n = 65,691) were observed between 1/1/2002 and 12/31/2015 using data obtained from 13 state cancer registries. Poisson regression was used to estimate IRRs controlling for age, race/ethnicity, and calendar year. IRRs and change-points were estimated using three reference populations (New York City (NYC), New York State (NYS), and a US population). IRRs for each cancer site varied in magnitude. Prostate and thyroid cancer IRRs were significantly greater in WTC-exposed responders, while colon and lung cancer IRRs were significantly lower compared with NYC, NYS, and US population reference groups. The range of IRRs varied by reference population. Mixed findings were observed for other cancers, as results were dependent on the reference group used. A significant change-point was found only for prostate cancer, and only when compared to a US population. Our findings suggest that reference population selection will influence the IRR, timing, and statistical significance of change-point estimation, varying with follow-up length.Keywords
Funding Information
- National Institute for Occupational Safety and Health (U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326, U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326)
- Agency for Toxic Substances and Disease Registry (U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750, U50/ATU272750)
- National Cancer Institute, United States (P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309, P30 CA013330, U58 DP006309)
This publication has 31 references indexed in Scilit:
- East meets West: ethnic differences in prostate cancer epidemiology between East Asians and CaucasiansChinese Journal of Cancer, 2012
- Lead-time in the European Randomised Study of Screening for Prostate CancerEuropean Journal of Cancer, 2010
- International epidemiology of prostate cancer: Geographical distribution and secular trendsMolecular Nutrition & Food Research, 2009
- Epidemiology and Pathophysiology of Prostate Cancer in African-American MenJournal of Urology, 2007
- Demographic and Past Screening Behaviors of Men Attending a Free Community Screening Program for Prostate CancerHealth Promotion Practice, 2006
- Geographic Patterns of Prostate Cancer Mortality and Variations in Access to Medical Care in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2005
- Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998Urology, 2004
- Lead time associated with screening for prostate cancerInternational Journal of Cancer, 2003
- A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's diseaseStatistics in Medicine, 2000
- A review of the healthy worker effect in occupational epidemiologyOccupational Medicine, 1999